Salesforce, the world’s leading CRM company announced that AstraZeneca, a global, science-driven biopharmaceutical company listed on the LSE, STO, and Nasdaq as AZN, has chosen Salesforce’s Agentforce Life Sciences for Customer Engagement as its unified global platform. The solution is designed to help AstraZeneca enhance interactions with healthcare professionals through data-driven insights and AI-powered engagement. This initiative supports AstraZeneca’s mission to advance science and deliver transformative medicines across oncology, rare diseases, cardiovascular, renal, metabolism, respiratory, and immunology therapies.
Health Technology Insights: Ryder and BJC Win Award for Healthcare Supply Chain Innovation
With Agentforce Life Sciences, Salesforce aims to create a new standard for intelligent engagement, allowing AstraZeneca to build stronger relationships with healthcare providers while accelerating business growth. The platform enables teams to focus on strategic customer outcomes and meaningful interactions rather than administrative tasks.
Health Technology Insights: Merck Reports Positive Phase 3 Results for DOR/ISL HIV Therapy
As part of this partnership, Salesforce will provide AstraZeneca with Agentforce 360 for Life Sciences as a global, end-to-end engagement solution. The platform supports several key capabilities including medical-commercial coordination by consolidating healthcare professional insights and providing contextual information across teams. Personalized engagement features will allow AstraZeneca to scale operations across key accounts, reimbursement, and field teams with next-best action recommendations, while also orchestrating and automating digital campaigns tailored to customer preferences. Through Model Context Protocol interoperability and Salesforce’s Agent Fabric, the platform enables seamless coordination of internal and external agent actions across field engagement, commercial operations, brands, and regions, allowing care teams and AI agents to work together efficiently.
Frank Defesche, Senior Vice President and General Manager of Life Sciences at Salesforce, said the collaboration represents a major step toward intelligent and agentic customer engagement in the life sciences sector. He emphasized that the partnership will empower AstraZeneca’s teams with advanced technology to deliver highly personalized engagement and support the global delivery of life-changing medicines to patients.
This collaboration positions AstraZeneca to leverage Salesforce’s AI-driven engagement tools to strengthen customer relationships, streamline operations, and ensure that healthcare professionals receive timely, relevant, and actionable insights, ultimately advancing patient care worldwide.
Health Technology Insights: Medscape Launches AI-Powered Medical Intelligence for HCPs
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
